some highlights of the above information, for those that can get into medscape.Dr Michael D. Gershon, MD is the worlds leading authority on the enteric nervous system and the person directly responsible for learning about the role of serotonin in the enteric nervous system and the role it plays in the functioning of the gut and the role it plays in communicating to the brain.
http://www.hosppract.com/issues/1999/07/gershon.htm Quotes from the Medscape information."Return to Irritable Bowel Syndrome: Taking Concepts Into Clinical PracticeIntegrating Current Concepts of Causality: Towards a Unifying HypothesisGervals Tougas, MDPhenomenology, Pathophysiology, and Symptomatology of Irritable Bowel SyndromeSlide 1. Integrating Current Concepts of Causality: Towards a Unifying HypothesisSlide 2. OutlineMy brief is to review 6 main
points:Look at how a phenomenon, a set of symptoms, relates to, or at least begins to relate to, a definable pathophysiologyTry to see to some extent how and why patients with irritable bowel syndrome IBS experience visceral painGet back to this area of mind and gut, and how events that seem to influence primarily psychological constraints, such as stress and psychological factors, will play a role in the perception of symptoms originating from the gutRemind us that in addition to these factors, primarily luminal and enteric factors, such as certain food types, infection, or inflammation, can also interact with these central nervous system CNS factors to produce painBegin to look at the role and the place of serotoninergic mechanisms in the modulation of these thingsLook at this in the broader sense of IBSSlide 3. Phenomenology and PathophysiologyWe know that in terms of its phenomenology, IBS is a condition that's associated with altered brain-gut communication. Pain plays a major role so that we have alterations, or at least generation of abnormal sensation within the gut. Emotions can modulate these symptoms to a large extent, but at the end they also have alterations of function characterized in general by either constipation or diarrhea. This is largely due to alterations of neuromodulation at the level of the enteric neurons and also at the level of central and autonomic pathways.""Return to Irritable Bowel Syndrome: Taking Concepts Into Clinical PracticeIntegrating Current Concepts of Causality: Towards a Unifying HypothesisGervals Tougas, MDPhenomenology, Pathophysiology, and Symptomatology of Irritable Bowel SyndromeSlide 1. Integrating Current Concepts of Causality: Towards a Unifying HypothesisSlide 2. OutlineMy brief is to review 6 main
points:Look at how a phenomenon, a set of symptoms, relates to, or at least begins to relate to, a definable pathophysiologyTry to see to some extent how and why patients with irritable bowel syndrome (IBS) experience visceral painGet back to this area of mind and gut, and how events that seem to influence primarily psychological constraints, such as stress and psychological factors, will play a role in the perception of symptoms originating from the gutRemind us that in addition to these factors, primarily luminal and enteric factors, such as certain food types, infection, or inflammation, can also interact with these central nervous system (CNS) factors to produce painBegin to look at the role and the place of serotoninergic mechanisms in the modulation of these thingsLook at this in the broader sense of IBSSlide 3. Phenomenology and PathophysiologyWe know that in terms of its phenomenology, IBS is a condition that's associated with altered brain-gut communication. Pain plays a major role so that we have alterations, or at least generation of abnormal sensation within the gut. Emotions can modulate these symptoms to a large extent, but at the end they also have alterations of function characterized in general by either constipation or diarrhea. This is largely due to alterations of neuromodulation at the level of the enteric neurons and also at the level of central and autonomic pathways.Slide 4. The Many Facets of IBSIBS has many dimensions. The symptom complex itself is characterized by abdominal discomfort associated with altered bowel habits. In addition to these, though, there is a substantial psychological comorbidity in many patients. At the same time, we have frequent extraintestinal manifestations associated with poor sleep, fatigue, changes in libido, and loss of energy, and a number of other symptoms, that often overlap with symptoms in the gut, outside of the colon, such as dyspeptic symptoms or noncardiac chest pain.We also know from increasing literature that many of these patients have other symptoms including irritable bladder, chronic fatigue, fibromyalgia, headaches, and a number of other symptoms. This is related to a number of abnormalities, some of them having to do with autonomic dysregulation and visceral hypersensitivity, altered pain modulation, abnormal health-seeking behavior and, to some degree, iatrogenesis.""Slide 5. Symptoms, Pathophysiology, and Pathogenesis in IBSIf we try to integrate this into a coherent map, we have symptoms that are subjectively definable, which then are associated with a series of complaints, either diarrhea, constipation, or abdominal pain, the whole spectrum of IBS. There is a pathophysiological basis to these symptoms that will vary in individual patients but seems to involve abnormalities of perception, epithelial function, and in some patients, motility, which then leads to symptom generation, and involves both external stressors, psychological stress, as well as genetic abnormalities and inflammation at the peripheral level.""Return to Irritable Bowel Syndrome: Taking Concepts Into Clinical PracticeIntegrating Current Concepts of Causality: Towards a Unifying HypothesisGervals Tougas, MDPhenomenology, Pathophysiology, and Symptomatology of Irritable Bowel SyndromeSlide 1. Integrating Current Concepts of Causality: Towards a Unifying HypothesisSlide 2. OutlineMy brief is to review 6 main
points:Look at how a phenomenon, a set of symptoms, relates to, or at least begins to relate to, a definable pathophysiologyTry to see to some extent how and why patients with irritable bowel syndrome (IBS) experience visceral painGet back to this area of mind and gut, and how events that seem to influence primarily psychological constraints, such as stress and psychological factors, will play a role in the perception of symptoms originating from the gutRemind us that in addition to these factors, primarily luminal and enteric factors, such as certain food types, infection, or inflammation, can also interact with these central nervous system (CNS) factors to produce painBegin to look at the role and the place of serotoninergic mechanisms in the modulation of these thingsLook at this in the broader sense of IBSSlide 3. Phenomenology and PathophysiologyWe know that in terms of its phenomenology, IBS is a condition that's associated with altered brain-gut communication. Pain plays a major role so that we have alterations, or at least generation of abnormal sensation within the gut. Emotions can modulate these symptoms to a large extent, but at the end they also have alterations of function characterized in general by either constipation or diarrhea. This is largely due to alterations of neuromodulation at the level of the enteric neurons and also at the level of central and autonomic pathways.Slide 4. The Many Facets of IBSIBS has many dimensions. The symptom complex itself is characterized by abdominal discomfort associated with altered bowel habits. In addition to these, though, there is a substantial psychological comorbidity in many patients. At the same time, we have frequent extraintestinal manifestations associated with poor sleep, fatigue, changes in libido, and loss of energy, and a number of other symptoms, that often overlap with symptoms in the gut, outside of the colon, such as dyspeptic symptoms or noncardiac chest pain.We also know from increasing literature that many of these patients have other symptoms including irritable bladder, chronic fatigue, fibromyalgia, headaches, and a number of other symptoms. This is related to a number of abnormalities, some of them having to do with autonomic dysregulation and visceral hypersensitivity, altered pain modulation, abnormal health-seeking behavior and, to some degree, iatrogenesis.Slide 5. Symptoms, Pathophysiology, and Pathogenesis in IBSIf we try to integrate this into a coherent map, we have symptoms that are subjectively definable, which then are associated with a series of complaints, either diarrhea, constipation, or abdominal pain, the whole spectrum of IBS. There is a pathophysiological basis to these symptoms that will vary in individual patients but seems to involve abnormalities of perception, epithelial function, and in some patients, motility, which then leads to symptom generation, and involves both external stressors, psychological stress, as well as genetic abnormalities and inflammation at the peripheral level.Slide 6. Visceral Pain in IBS"To summarize, we know that there is alteration of visceral perception. There are good data to that effect and increasingly sophisticated ways to measure this, but in most patients, visceral hypersensitivity seems to play a role. In a substantial group of patients, luminal events, in particular infection and some degree of mild irritation, can alter visceral perception and lead to symptoms. Psychological factors also play a role in altering visceral perception and the vigilance to symptoms originating from the gut.""Slide 7. Increased Sensitivity to Balloon Distention in IBS PatientsOne of the most convincing studies was done by Bradette and coworkers. This was a simple study that looked at differences in visceral perception to balloon distension in patients with IBS and compared it to healthy subjects. Both the threshold to discomfort and the threshold to pain were much lower in patients with IBS than in healthy controls, suggesting that, in fact, there was visceral hypersensitivity in those patients.""Slide 8. fMRI Imaging With Rectal Distension in IBSThings have progressed a fair bit since then and we can demonstrate that, in addition to symptomatic abnormalities, there are significant differences that we can see between IBS patients and control subjects using functional magnetic resonance imaging fMRI, brain imaging, during colonic distension. These abnormalities are in 2 main parts. One is the somatosensory areas of the brain and the other is the prefrontal cortex region of the brain, each of which deals with different aspects of pain symptomatology.""Slide 9. Altered Pain Perception in IBSUp to 95% of patients with IBS will have altered pain perception. They will have lower thresholds, so they experience symptoms at much lower volumes than healthy controls. They also have an increased intensity of the sensation elicited by distension at a given volume, and they have increased referral of these sensory perceptions in response to rectal distension when compared with healthy patients.This is not something that we see very often in normal subjects and there's also different somatic pain perception in a subset of IBS patients, but by no means all.""Slide 10. Different Sensations, Different DestinationsWhy would that be? There are 2 regions in the brain that are involved with the perception of visceral sensation. The first one is the somatosensory cortex that is associated with the perception of noxious stimulation and painful stimuli. This region closely interacts with the limbic system, which is the part of the brain that is involved with the neuroendocrine and autonomic responses associated with the perception of pain. This is more of a hard-wired reflex area, but it plays a very important role in modulating responses in areas involved more directly with pain perception. These areas are also associated with aspects such as mood, hedonic behavior, and motivation, which play a very important role in the psychological make-up and modulation of these visceral sensations.""Slide 11. Visceral Pain and the Autonomic PathwayA lot of this is mediated through autonomic responses, and the important aspect here is that perception of pain in itself elicits responses that will then, in turn, alter the response and the reactivity of the gut. Eliciting painful visceral sensation will involve activation of sympathetic spinal afferents that, in turn, will lead to homeostatic visceral responses that will be associated with vagal afferent responses leading to symptoms such as satiety, nausea, and even bloating. These afferent pathways will then lead to efferent responses that are associated with visceral perception. And this is important because these pathways can in turn modulate the intensity of the afferent input.""Slide 12. Key ConceptsTo summarize, IBS patients display evidence of a central hyperresponsiveness to visceral stimuli and events, and this occurs at the level of the brain. In response to these pain stimuli, IBS patients have a visceral hyperresponsiveness to luminal events and also to central, more psychologically derived events, and this is occurring at the level of the gut. The understanding of these mechanisms is still evolving and begins to explain the 2 dimensions that we see with IBS patients, pain and altered bowel function.""Slide 13. Emotions and Visceral PerceptionEmotions modulate pain perception by several dimensions. One of them is that if you've experienced unpleasant or uncomfortable symptoms, you will have an increased vigilance to these visceral stimuli. And to some degree, the same seems to be occurring at the level of visceral pain. This involves both cortical and brain stem nuclei and a large degree of autonomic modulation. The central nervous system increases the perception of symptoms at the level of the gut. There is a clear presence of visceral hyperalgesia that can be related in many situations and experimental paradigms to very early trauma during childhood or infancy, and also seems to be associated with very stressful, psychological events, such as abuse or posttraumatic stress disorder. This raises the issue of whether there is an element of neuroplasticity involving altered perception in addition to the cortical activation that comes from altered symptoms.Furthermore, a number of studies have shown that patients with IBS have altered autonomic activity. While this is not completely described yet, it is associated with an increase or altered visceral responsiveness in many of these patients. A final aspect is that these symptoms lead to increased health-seeking behavior and use of healthcare.""Slide 14. Auditory Stress Alters Perceptual and Emotional Ratings of Visceral StimuliOne of the best studies looking at this is a study that looked at auditory stress and showed that an unpleasant external stressor, a noise in this case, altered both the perceptual and emotional rating that you experience in response to a visceral stimulus. In this study published a year ago, a control subject had responses that were measured in response to either a relaxing stimulus or a stressful stimulus, a conflicting sound in both ears. In patients with IBS, the same stimulus led to an increased degree of unpleasantness at set pressure distension. Similarly, it had the same effect on the anger rating, a psychological measure of psychological stress.""Slide 16. Enteric Factors and IBS SymptomsWhen we look at the other dimension, enteric factors, many patients tell us that certain foods will produce symptoms. It is difficult to determine whether this is a pharmacological, a chemical, or even an immune mechanism. Also, low-grade inflammation is present in a small subset of patients with functional symptoms. There is increasing awareness that in the substantial group of patients, although the proportion remains to be determined, infectious events seem to lead to the subsequent development of IBS. Sometimes this occurs as a single precipitant, but in many studies the biggest predictor of the subsequent development of symptoms following an enteric infection is other factors, such as psychological stress or an adverse life event a few weeks or a few months preceding the infection. Clearly, there is a role for infections but this is in association with central factors.Slide 16. Enteric Factors and IBS SymptomsWhen we look at the other dimension, enteric factors, many patients tell us that certain foods will produce symptoms. It is difficult to determine whether this is a pharmacological, a chemical, or even an immune mechanism. Also, low-grade inflammation is present in a small subset of patients with functional symptoms. There is increasing awareness that in the substantial group of patients, although the proportion remains to be determined, infectious events seem to lead to the subsequent development of IBS. Sometimes this occurs as a single precipitant, but in many studies the biggest predictor of the subsequent development of symptoms following an enteric infection is other factors, such as psychological stress or an adverse life event a few weeks or a few months preceding the infection. Clearly, there is a role for infections but this is in association with central factors.""Slide 17. Pathophysiology of Postinfectious IBSIn postinfectious IBS patients, there is accelerated gut transit in many patients, increased visceral sensitivity, and evidence for alteration of intestinal permeability, something very relevant to chronic diarrhea in these patients. There's clear evidence in many patients of increased presence of enterochromaffin EC cells in the colon. Therefore, there is the possibility of increased release of serotonin 5-HT in these patients.""Slide 18. Serotonin and the Neural Control of Digestive FunctionsSerotonin is involved at just about every level of the communication between gut and brain, both going from gut to brain and then from brain to gut. One appealing therapeutic avenue is to focus on the site where most of the 5-HT is being released and try to affect outcome and symptoms by modulating symptoms at the level of the gut trying to avoid the possible side effects that may come with more central modulation of serotoninergic pathways.""Slide 19. Plasma 5-HT Levels in IBS vs ControlsWe know that 5-HT release is actually increased in IBS patients with the diarrhea-dominant component, suggesting that, again, 5-HT may play a role in subsets of patients with IBS.""Slide 20. Serotonin and EC Cells in Altered GI MotilityThis may be further demonstrated in the sense that there is increased circulating 5-HT in patients with diarrhea-dominant IBS and increased EC cell population in the gut, whereas in some subgroup of patients with chronic constipation, there appears to be a decreased number of EC cells suggesting that, if we stimulate serotoninergic pathways, we might be able to improve symptoms in these patients.""Slide 21. SummaryIn summary, IBS is affected and modulated by many factors. Some of them have to do with emotional dimensions, others are more related to visceral function and sensation. This is probably, to some extent, associated with a dysfunction or a disorder of gut-brain communication involving both afferent and efferent pathways going to and from the gut. There is good evidence to suggest that 5-HT is a central mediator in the regulation of these visceral functions, and its modulation may provide an appealing form of therapy for a proportion of patients with IBS."